Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule
- 1 September 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 104 (9), 2824-2831
- https://doi.org/10.1002/jps.24509
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Oxidation of Therapeutic Proteins and Peptides: Structural and Biological ConsequencesPharmaceutical Research, 2013
- Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodiesMolecular Immunology, 2011
- Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymesmAbs, 2010
- Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fcγ receptorsMolecular Immunology, 2009
- Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRnProtein Science, 2009
- Protein Oxidation During Long Storage: Identification of the Oxidation Sites in Dihydrofolate Reductase from Escherichia coli through LC-MS and Fragment StudiesThe Journal of Biochemistry, 2009
- Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation PathwaysJournal of Pharmaceutical Sciences, 2008
- Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein GJournal of Chromatography B, 2008
- Structure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine OxidationBiochemistry, 2008
- Conditions Promoting Metal‐Catalyzed Oxidations during Immobilized Cu—Iminodiacetic Acid Metal Affinity ChromatographyBiotechnology Progress, 1995